Pasquine T - Search Results

1

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.

Abelson MB, Gomes PJ, Pasquine T, Edwards MR, Gross RD, Robertson SM. Abelson MB, et al. Among authors: pasquine t. Allergy Asthma Proc. 2007 Jul-Aug;28(4):427-33. doi: 10.2500/aap.2007.28.3014. Allergy Asthma Proc. 2007. PMID: 17883910 Clinical Trial.

2

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.

Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, Wells DT, Bergamini MV, Robertson SM. Abelson MB, et al. Among authors: pasquine ta. Clin Ther. 2004 Aug;26(8):1237-48. doi: 10.1016/s0149-2918(04)80065-1. Clin Ther. 2004. PMID: 15476905 Clinical Trial.

3

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.

Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM. Abelson MB, et al. Among authors: pasquine ta. Curr Med Res Opin. 2005 May;21(5):683-91. doi: 10.1185/030079905X43622. Curr Med Res Opin. 2005. PMID: 15969867 Clinical Trial.

4

Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.

Vogelson CT, Abelson MB, Pasquine T, Stephens DM, Gamache DA, Gross RD, Robertson SM, Yanni JM. Vogelson CT, et al. Among authors: pasquine t. Allergy Asthma Proc. 2004 Jan-Feb;25(1):69-75. Allergy Asthma Proc. 2004. PMID: 15055565 Clinical Trial.

5

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis.

Scoper SV, Berdy GJ, Lichtenstein SJ, Rubin JM, Bloomenstein M, Prouty RE, Vogelson CT, Edwards MR, Waycaster C, Pasquine T, Gross RD, Robertson SM. Scoper SV, et al. Among authors: pasquine t. Adv Ther. 2007 Nov-Dec;24(6):1221-32. doi: 10.1007/BF02877768. Adv Ther. 2007. PMID: 18165204 Clinical Trial.

6

Safety and tolerability of olopatadine 0.2% in children and adolescents.

Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Lichtenstein SJ, et al. Among authors: pasquine ta. J Ocul Pharmacol Ther. 2007 Aug;23(4):366-71. doi: 10.1089/jop.2007.0013. J Ocul Pharmacol Ther. 2007. PMID: 17803435 Clinical Trial.

7

Influence of diet on de novo lipogenesis in artificially-fed 15- and 20-day-old Zucker fatty rats.

Thenen SW, Godbole VY, Pasquine TA, Grundleger ML. Thenen SW, et al. Among authors: pasquine ta. Int J Obes. 1984;8(1):1-12. Int J Obes. 1984. PMID: 6706456

8

Influence of diet on glucose metabolism of soleus muscle in artificially-fed 15- and 20-day-old Zucker fatty rats.

Grundleger ML, Godbole VY, Pasquine TA, Thenen SW. Grundleger ML, et al. Among authors: pasquine ta. Int J Obes. 1984;8(1):13-20. Int J Obes. 1984. PMID: 6368433

9

Composition of rat milk from day 5 to 20 of lactation and milk intake of lean and preobese Zucker pups.

Godbole VY, Grundleger ML, Pasquine TA, Thenen SW. Godbole VY, et al. Among authors: pasquine ta. J Nutr. 1981 Mar;111(3):480-7. doi: 10.1093/jn/111.3.480. J Nutr. 1981. PMID: 7193715

10

Fenfluramine effects on insulin resistance and lipogenesis in genetically obese (ob/ob) mice.

Pasquine TA, Thenen SW. Pasquine TA, et al. Proc Soc Exp Biol Med. 1981 Feb;166(2):241-8. doi: 10.3181/00379727-166-41053. Proc Soc Exp Biol Med. 1981. PMID: 7010362 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page